Tern extends Device Authority convertible loan note maturity date

Money and Investment

Tern Plc (LON:TERN), the investment company specialising in the Internet of Things, has announced that the maturity date for all convertible loan notes provided to Device Authority Limited by Tern, Alsop Louie Partners and the George Samenuk Family Trust et al., has been extended to 31 March 2022.  

All existing repayment and conversion rights, automatic and at the holder’s option, have also been extended to 31 March 2022.  All other terms of these loan notes remain unchanged and as previously announced.

The outstanding convertible loan balance payable by Device Authority to Tern currently stands at US$4.3 million, excluding US$0.6 million of interest accrued to date.

We’ll keep you in the loop!

Join 1,000's of investors who read our articles first

We don’t spam! Read our privacy policy for more info.

Share on:
Find more news, interviews, share price & company profile here for:

Latest Company News

A new frontier for medical device trust and patient safety

Connected medical device risk is rising and a platform that automates identity, credential and data‑protection lifecycles may become an infrastructure segment worth watching.

When HCP Dialogue Becomes Quantifiable Intelligence

Talking Medicines’ DrugVoice platform turns real‑world HCP dialogue into measurable insight, letting brand‑teams forecast message resonance before launch.

Immersive cardiac training tech gaining ground in high-stakes procedures

Immersive simulation platforms like Fundamental XR are shaping the infrastructure behind safer, faster adoption of intracardiac procedures.

Why psychological safety could be the culture signal investors are missing

Psychological safety is not a soft measure, it is a risk signal investors can’t afford to overlook.

Connected care enters a vital security frontier

Device Authority’s platform automates how medical‑devices earn and maintain trust in a connected world, turning identity into security at scale.

Surgical simulation steps into a new phase in ophthalmology

A new model for immersive surgical training is taking shape in ophthalmology, offering a blueprint for broader medical adoption.

Search

Search